Highlights Therma Bright Inc.

Equities

THRM

CA8834261080

Market Closed - Toronto S.E. Other stock markets 08:50:40 08/05/2024 pm IST			5-day change	1st Jan Change
0.01 ^CAD	0.00%		0.00%	-60.00%

01/04	Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
10/01	Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	02/04	CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	10/01	CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	05/01	CI
Therma Bright Prepares Fda 513(G) Review Therma Bright Prepares FDA 513(G) Review Analyzer	29/11	CI
Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States	02/11	CI
Therma Bright Inc Signs Hero Lifecare to A U.S. Distribution Partner for Marketing and Selling the Venowave Device	13/23/13	CI
Therma Bright Inc. Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description	07/23/07	CI
Therma Bright Inc. Provides Update on Venowave for the United States and Texas Region	30/23/30	CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	29/23/29	CI
Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device	08/23/08	CI
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	04/23/04	CI
Therma Bright Inc. Provides an Update on Its Partnership with Inretio Inc	23/23/23	CI
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	23/22/23	CI
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	28/22/28	CI
Therma Bright Agrees to Buy Exclusive License for Patented Digital Cough-Based Technology to Detect Respiratory Diseases	18/22/18	MT
Therma Bright Receives Payment for Initial Venowave Sales	20/22/20	CI
Therma Bright Inc. Provides Update on FDA EUA Review Process	12/22/12	CI
Therma Bright Inc. Provides Updates on Applications for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test	04/22/04	CI
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	30/22/30	CI
Therma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care	24/22/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Therma Bright Inc.

Equities

THRM

CA8834261080

Highlights

Filters